Ella, R., Vadrevu, K. M., Jogdand, H., Prasad, S., Reddy, S., Sarangi, V., . . . Bhargava, B. (2021). Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: A double-blind, randomised, phase 1 trial. Lancet Infect Dis.
استشهاد بنمط شيكاغوElla, Raches, et al. "Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine, BBV152: A Double-blind, Randomised, Phase 1 Trial." Lancet Infect Dis 2021.
MLA استشهادElla, Raches, et al. "Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine, BBV152: A Double-blind, Randomised, Phase 1 Trial." Lancet Infect Dis 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.